Cargando…

Implication of the p53-Related miR-34c, -125b, and -203 in the Osteoblastic Differentiation and the Malignant Transformation of Bone Sarcomas

The formation of the skeleton occurs throughout the lives of vertebrates and is achieved through the balanced activities of two kinds of specialized bone cells: the bone-forming osteoblasts and the bone-resorbing osteoclasts. Impairment in the remodeling processes dramatically hampers the proper hea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jacques, Camille, Tesfaye, Robel, Lavaud, Melanie, Georges, Steven, Baud’huin, Marc, Lamoureux, François, Ory, Benjamin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226610/ https://www.ncbi.nlm.nih.gov/pubmed/32230926 http://dx.doi.org/10.3390/cells9040810

Ejemplares similares

The p53 Family Members p63 and p73 Roles in the Metastatic Dissemination: Interactions with microRNAs and TGFβ Pathway
por: Rodriguez Calleja, Lidia, et al.
Publicado: (2022)

Tracking Targets of Dynamic Super-Enhancers in Vitro to Better Characterize Osteoclastogenesis and to Evaluate the Effect of Diuron on the Maturation of Human Bone Cells
por: Tesfaye, Robel A., et al.
Publicado: (2023)

miRNA-193a-5p repression of p73 controls Cisplatin chemoresistance in primary bone tumors
por: Jacques, Camille, et al.
Publicado: (2016)

Loss of miR-198 and -206 during primary tumor progression enables metastatic dissemination in human osteosarcoma
por: Georges, Steven, et al.
Publicado: (2018)

Targeting the epigenetic readers in Ewing Sarcoma inhibits the oncogenic transcription factor EWS/Fli1
por: Jacques, Camille, et al.
Publicado: (2016)

Ewing sarcoma from molecular biology to the clinic
por: Dupuy, Maryne, et al.
Publicado: (2023)

Mechanisms of Resistance to Conventional Therapies for Osteosarcoma
por: Marchandet, Louise, et al.
Publicado: (2021)

Ribosomopathies: New Therapeutic Perspectives
por: Orgebin, Emilien, et al.
Publicado: (2020)

Origin and Therapies of Osteosarcoma
por: Moukengue, Brice, et al.
Publicado: (2022)

Clusterin inhibition using OGX-011 synergistically enhances zoledronic acid activity in osteosarcoma
por: Lamoureux, Francois, et al.
Publicado: (2014)

Molecular Chaperones in Osteosarcoma: Diagnosis and Therapeutic Issues
por: Lallier, Morgane, et al.
Publicado: (2021)

Sostdc1: A soluble BMP and Wnt antagonist that is induced by the interaction between myeloma cells and osteoblast lineage cells
por: Faraahi, Z., et al.
Publicado: (2019)

Corrigendum to “Sostdc1: A soluble BMP and Wnt antagonist that is induced by the interaction between myeloma cells and osteoblast lineage cells” [Bone 122 (May 2019) 82–92]
por: Faraahi, Z., et al.
Publicado: (2019)

Molecular Alterations Associated with Osteosarcoma Development
por: Ando, Kosei, et al.
Publicado: (2012)

TH1579, MTH1 inhibitor, delays tumour growth and inhibits metastases development in osteosarcoma model
por: Moukengue, Brice, et al.
Publicado: (2020)

Overexpression of the Ubiquitin Specific Proteases USP43, USP41, USP27x and USP6 in Osteosarcoma Cell Lines: Inhibition of Osteosarcoma Tumor Growth and Lung Metastasis Development by the USP Antagonist PR619
por: Lavaud, Mélanie, et al.
Publicado: (2021)

Preliminary Results of the “Capasquelet” Technique for Managing Femoral Bone Defects—Combining a Masquelet Induced Membrane and Capanna Vascularized Fibula with an Allograft
por: Combal, Alexis, et al.
Publicado: (2021)

Genetically transforming human osteoblasts to sarcoma: development of an osteosarcoma model
por: Yang, Yi, et al.
Publicado: (2017)

Interaction of Cutibacterium ( formerly Propionibacterium) acnes with bone cells: a step toward understanding bone and joint infection development
por: Aubin, Guillaume Ghislain, et al.
Publicado: (2017)

The Methylation of the p53 Targets the Genes MIR-203, MIR-129-2, MIR-34A and MIR-34B/C in the Tumor Tissue of Diffuse Large B-Cell Lymphoma
por: Voropaeva, Elena N., et al.
Publicado: (2022)

miR-34s keep osteoblasts bone idle
por: Short, Ben
Publicado: (2012)

DKK1 Induced by 1,25D3 Is Required for the Mineralization of Osteoblasts
por: Jo, Sungsin, et al.
Publicado: (2020)

Small animal models for the study of bone sarcoma pathogenesis:characteristics, therapeutic interests and limitations
por: Jacques, Camille, et al.
Publicado: (2018)

(125)I brachytherapy: a useful treatment to control painful osteoblastic bone metastases
por: Liu, Yiming, et al.
Publicado: (2022)

1,2,5-Oxadiazolo[3,4-b]glycyrrhetinic acid
por: Hu, Jun, et al.
Publicado: (2009)

Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms
por: Chim, Chor Sang, et al.
Publicado: (2011)

Schedule of experiment R203
por: Jarlskog, G
Publicado: (1973)

Quadrupole moment of $^{203}$Fr
por: Wilkins, S G, et al.
Publicado: (2017)

Posttranscriptional deregulation of Src due to aberrant miR34a and miR203 contributes to gastric cancer development
por: Hao, Qiang, et al.
Publicado: (2013)

RF34 | PMON203 Copy Number Variant Analysis Reveals Novel Candidate Genes Associated with Primary Ovarian Insufficiency
por: Franca, Monica, et al.
Publicado: (2022)

Downregulation of Runx2 by 1,25-Dihydroxyvitamin D(3) Induces the Transdifferentiation of Osteoblasts to Adipocytes
por: Kim, Jung Ha, et al.
Publicado: (2016)

Serenaden K. 185 & K. 203
por: Mozart, Wolfgang Amadeus, 1756-1791
Publicado: (1990)

The decays of $^{205}$Po and $^{203}$Po
por: Astner, G, et al.
Publicado: (1972)

Health Tract No. 203: Household Knowledge
Publicado: (1865)

Health Tract No. 203: Household Knowledge
Publicado: (1864)

MiR-34a and miR-203 Inhibit Survivin Expression to Control Cell Proliferation and Survival in Human Osteosarcoma Cells
por: Chen, Xun, et al.
Publicado: (2016)

MiR-155-5p and MiR-203a-3p Are Prognostic Factors in Soft Tissue Sarcoma
por: Greither, Thomas, et al.
Publicado: (2020)

ELECTRON MICROSCOPIC EXAMINATION OF SUBCELLULAR FRACTIONS : II. Quantitative Analysis of the Mitochondrial Population Isolated from Rat Liver
por: Baudhuin, Pierre, et al.
Publicado: (1967)

Teratogen-induced alterations in microRNA-34, microRNA-125b and microRNA-155 expression: correlation with embryonic p53 genotype and limb phenotype
por: Gueta, Keren, et al.
Publicado: (2010)

Monocarboxylate transporter-1 promotes osteoblast differentiation via suppression of p53, a negative regulator of osteoblast differentiation
por: Sasa, Kiyohito, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_bcrmq34bdlr8dku8hvb2l18qnj